human | Q5 |
P735 | given name | Bruce | Q579371 |
Bruce | Q579371 | ||
P106 | occupation | researcher | Q1650915 |
Q21129418 | "It's Not What You Say, But How You Say it": A Reciprocal Temporo-frontal Network for Affective Prosody |
Q55023309 | 34.4 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN THE COMMUNITY: A NEURODEVELOPMENTAL PERSPECTIVE. |
Q30239880 | A quantitative meta-analysis of olfactory dysfunction in mild cognitive impairment |
Q79781322 | A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia |
Q30484607 | Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands |
Q48420505 | Age-related differences in brain activation during emotional face processing |
Q44125843 | Alpha2-noradrenergic effects on ERP and behavioral indices of auditory information processing |
Q36579986 | Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia |
Q48438823 | An fMRI study of facial emotion processing in patients with schizophrenia |
Q36024712 | An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis |
Q36474142 | An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia |
Q30450376 | Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia |
Q33550568 | Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study |
Q52016967 | Apolipoprotein E genotype and odor identification in schizophrenia. |
Q50904398 | Association between facial emotion recognition and odor identification in schizophrenia. |
Q35243704 | Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). |
Q37345525 | Auditory Oddball fMRI in Schizophrenia: Association of Negative Symptoms with Regional Hypoactivation to Novel Distractors |
Q30459822 | Auditory processing under cross-modal visual load investigated with simultaneous EEG-fMRI. |
Q48705816 | Behavioral and physiological findings of gender differences in global-local visual processing |
Q48516772 | Brain activation during facial emotion processing |
Q77487050 | Brain region and sex differences in age association with brain volume: a quantitative MRI study of healthy young adults |
Q41702173 | California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). |
Q48531907 | Chemosensory anxiety cues enhance the perception of fearful faces - An fMRI study |
Q30400666 | Chemosensory anxiety cues moderate the experience of social exclusion - an fMRI investigation with Cyberball |
Q27303961 | Comparison of auditory and visual oddball fMRI in schizophrenia |
Q30400031 | Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study |
Q38431173 | Computing the Social Brain Connectome Across Systems and States |
Q39149363 | Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research |
Q42428133 | Corrigendum: The Influence of Menstrual Cycle and Androstadienone on Female Stress Reactions: An fMRI Study |
Q42412826 | Corrigendum: The Influence of Task-Irrelevant Flankers Depends on the Composition of Emotion Categories |
Q44630966 | Crossmodal interactions in audiovisual emotion processing |
Q48122394 | Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia |
Q30419989 | Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. |
Q38760980 | Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension |
Q37376392 | Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia? |
Q44736082 | Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential |
Q44374774 | Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice |
Q35718069 | Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia |
Q35822123 | Emotional graphic cigarette warning labels reduce the electrophysiological brain response to smoking cues |
Q35096082 | Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia |
Q34640156 | Facial emotion recognition in schizophrenia: when and why does it go awry? |
Q41435204 | Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). |
Q47900362 | Follow your nose: Implicit spatial processing within the chemosensory systems |
Q30359621 | Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History |
Q30367047 | Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. |
Q30439012 | Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia |
Q48354920 | Hemodynamic responses in neural circuitries for detection of visual target and novelty: An event-related fMRI study |
Q34777987 | Identification of pleasant, neutral, and unpleasant odors in schizophrenia |
Q44599650 | Impairment of Odor Hedonics in Men With Schizophrenia |
Q52691765 | Impulsive aggression and response inhibition in Attention-Deficit/Hyperactivity Disorder and Disruptive Behavioral Disorders: findings from a systematic review. |
Q50661510 | Incongruence effects in crossmodal emotional integration. |
Q40551081 | Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains |
Q36944287 | Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia |
Q28256332 | Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia |
Q30443158 | Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? |
Q48348964 | Low olfactory bulb volume in first-degree relatives of patients with schizophrenia |
Q44181836 | Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures |
Q37451449 | Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis |
Q35016313 | Misdiagnosis of schizophrenia in a patient with psychotic symptoms. |
Q39123744 | Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia |
Q30440035 | Modulation of affective face processing deficits in Schizophrenia by congruent emotional sounds |
Q37429365 | Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia |
Q33885925 | Mouse model predicts effects of smoking and varenicline on event-related potentials in humans |
Q30494699 | Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia |
Q35883039 | Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function |
Q35637422 | Neurocognitive performance in family-based and case-control studies of schizophrenia |
Q30491325 | Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures |
Q46048238 | Not pitch perfect: sensory contributions to affective communication impairment in schizophrenia |
Q36471538 | Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients |
Q42733631 | Olfaction and schizophrenia clinical risk status: just the facts |
Q48393091 | Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures |
Q36824498 | Olfactory physiological impairment in first-degree relatives of schizophrenia patients |
Q50019814 | Olfactory processing in bipolar disorder, major depression, and anxiety |
Q37581121 | Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis |
Q36474440 | Olfactory receptor neuron dysfunction in schizophrenia |
Q33948950 | Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings |
Q40530811 | Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine |
Q37609143 | Persistence of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort: a prospective two-year follow-up |
Q35776479 | Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance |
Q36315595 | Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: testing the evidence for an endophenotypic marker |
Q46412597 | Phenylthiocarbamide perception in patients with schizophrenia and first-degree family members |
Q48375396 | Physiologic impairment of olfactory stimulus processing in schizophrenia |
Q36004516 | Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study |
Q30483719 | Profile of auditory information-processing deficits in schizophrenia |
Q30483462 | Proline affects brain function in 22q11DS children with the low activity COMT 158 allele |
Q30489172 | Reduced posterior nasal cavity volume: a gender-specific neurodevelopmental abnormality in schizophrenia |
Q35243464 | Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies |
Q35176176 | Scent of a disorder: olfactory functioning in schizophrenia |
Q30478984 | Scents and nonsense: olfactory dysfunction in schizophrenia |
Q37637086 | Sex differences in familiality effects on neurocognitive performance in schizophrenia |
Q52085356 | Smaller nasal volumes as stigmata of aberrant neurodevelopment in schizophrenia. |
Q44440100 | Statistical tests for fMRI based on experimental randomization |
Q35759907 | Striatal intrinsic reinforcement signals during recognition memory: relationship to response bias and dysregulation in schizophrenia |
Q47621028 | Structural anomalies of the peripheral olfactory system in psychosis high-risk subjects |
Q50712794 | Successful multi-site measurement of antisaccade performance deficits in schizophrenia. |
Q36684929 | Task- and resting-state functional connectivity of brain regions related to affection and susceptible to concurrent cognitive demand |
Q41043579 | Task-irrelevant fear enhances amygdala-FFG inhibition and decreases subsequent face processing |
Q48553582 | Temporal Lobe Volume Decrements in Psychosis Spectrum Youths |
Q30491329 | The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration |
Q27316538 | The Influence of Menstrual Cycle and Androstadienone on Female Stress Reactions: An fMRI Study |
Q36934742 | The Influence of Task-Irrelevant Flankers Depends on the Composition of Emotion Categories |
Q34344448 | The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth |
Q40506415 | The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components |
Q36782477 | The influence of semantic processing on odor identification ability in schizophrenia |
Q24735452 | The modular neuroarchitecture of social judgments on faces |
Q35243586 | The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2 |
Q30387378 | Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. |
Q34501245 | Ventrolateral prefrontal cortex and the effects of task demand context on facial affect appraisal in schizophrenia |
Q36862072 | Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia |
Q27303941 | Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications |
Q48257591 | Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging |
Q48703760 | Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities |
Q35096032 | Working memory for complex figures: an fMRI comparison of letter and fractal n-back tasks |
Search more.